Search

We have started a small association in Switzerland called phageSuisse to bring different actors of phage therapy in Switzerland together. With this association, we launched a small webinar series. The first webinar will be on December 1st b

Earlier this month we posted that Adaptive Phage Therapeutics received emergency FDA authorization to treat a group of COVID-19 patients in Texas with A. baumannii infections. Now, they've received expanded access authorization to use their

Ruby Lin (Wesmead Institute for Medical Research, Australia) and colleagues published a Nature Microbiology blog post on their work toward establishing an Australian Phage Network. This post follows up on their Nature Microbiology paper fro

Fernando Gordillo Altamirano and Jeremy Barr (Monash University) published a new perspective in Current Opinion in Biotechnology entitled "Unlocking the next generation of phage therapy: the key is in the receptors". They argue that identif

Check out this ID Hub podcast, where Juandem Agendia and Sarah Alexander of the National Collection of Type Cultures (NCTC, UK) discuss phages, the function of the NCTC, and the importance of depositing phages in the NCTC collection to impr

Britt Koskella (Associate Professor in Integrative Biology at the University of California, Berkeley) has received the Fleming Prize from the Microbiology Society (awarded to an early career researcher who has achieved an outstanding resear

Locus Biosciences signed a contract with CARB-X to advance a $14 million precision medicine program to develop their crPhage™ product, which targets Klebsiella pneumoniae infections.

The C-SNIPER project (Campylobacter-Specific Nullification via Innovative Phage-mediated Enteropathogen Reduction), led by AZTI (a technology center in Spain) received funding from the European Institute of Innovation & Technology. The proj

Michela Gambino (University of Copenhagen) and colleagues published a new review in Current Opinion in Biotechnology on modernizing phage-based control of zoonotic pathogens in food and animal production. They suggest a holistic approach bu

Sofia Dahlman (Monash University) and colleagues published a new review in Current Opinion in Biotechnology on phages to shape the gut microbiota. They discuss current understanding of phages within the gut (from infancy, to adulthood, to d

Some elements, termed phage-plasmids, are known to be both plasmids and phages. Eugen Pfeifer (Institut Pasteur) and colleagues screened 14,000 phages and plasmids and found 780 phage-plasmids across very diverse bacterial phyla, suggesting

The third iVoM event will be Thursday, November 19, 4pm GMT, and the theme will be "Virus-host interaction: overcoming cell barriers". It will feature talks by: Martin J. Loessner (ETH Zurich, Zurich, Switzerland) Carlos São-José (Universi

The third iVoM event will be Thursday, November 19, 4pm GMT, and the theme will be "Virus-host interaction: overcoming cell barriers". It will feature talks by: Martin J. Loessner (ETH Zurich, Zurich, Switzerland) Carlos São-José (Universi

Adaptive Phage Therapeutics has deployed their PhageBank™ in Texas to treat COVID-19 patients suffering from life-threatening carbapenem resistant Acinetobacter baumannii (CRAB). Eight of these patients have so far received PhageBank™ thera

BiomX has announced the dosing of their first subject in their Phase 1a clinical study testing the safety, pharmacokinetics and oral delivery of a phage therapy candidate for treatment of Inflammatory Bowel Disease. Results are expected in

Jiawei Wang (Monash University) and colleagues published a new paper in Nucleic Acids Research describing AcrHub: an integrative hub for investigating, predicting and mapping anti-CRISPR proteins.

Jolene Ramsey (Texas A&M University) and colleagues published a new paper in PLoS Computational Biology describing Galaxy and Apollo as a biologist-friendly interface for high-quality cooperative phage genome annotation. Researchers can use

Katie Bodner (Stanford University) and colleagues published a new paper in STAR Protocols showing how to engineer phages for live-cell imaging of prophage induction inside mammalian cells.

Yu Lin (University of Sydney) and colleagues published a new paper in the International Journal of Pharmaceutics showing storage stability of phage-ciprofloxacin combination powders against Pseudomonas aeruginosa respiratory infections. The

PhageOption 2020 will take place at Universidad de los Andes, Cartagena, Colombia from November 4-6, 2020. The conference will focus on the role phages can play in controlling MDR bacteria in human and agriculture fields. Organizers: Resear